A novel drug delivery system based on amorphous zeolite derived from kanemite for doxorubicin (Dox) has been constructed. Structural analysis indicated that the initial Na-Ka was an orthorhombic structure with lattice parameters of a = 7.267(9)Å, b = 21.03(3)Å, and c = 4.878(8)Å. After protonation of Na-Ka by HCl solution, the resulting H-Ka was an zeolite with orthorhombic structure, and its lattice parameters are a = 7.45(2)Å, b = 11.85(5)Å, and c = 4.905(9)Å. Then the H-Ka was reacted with tetra-n-butyl ammonium hydroxide (TBAOH) solution, yielding Ka-TBA colloid suspension, and the Ka-TBA sediment exhibited amorphous state. While the Ka-TBA colloid suspension was reacted with doxorubicin (Dox) hydrochloride solution by ion exchange, the yielded Ka-Dox was amorphous. Composition analyses revealed that the chemical formula of Na-Ka, H-Ka, and Ka-Dox was estimated to be NaHSi2O4(OH)2·2.0H2O, H2Si2O5·0.72H2O, and H1.82(C27H30NO11)0.18·Si2O4(OH)2·1.31H2O, respectively. The loading capacity of Ka-Dox for Dox was about 35.24%. Drug release suggested that the Ka-Dox exhibited extremely slow and sustained release of drug in phosphate buffer solution (PBS, pH = 7.4), and the drug release percentages were 2.42%, 2.84%, 3.12%, and 3.40% after 24 h, 48 h, 72 h, and 96 h, respectively. This extremely slow and sustained release of drug may be potential application in the medical field, such as maintaining stable blood drug concentrations over prolonged periods, improving the compliance and safety of drug treatment, and reducing the toxic side effects.